Related Experiment Video
Updated: Aug 6, 2026
07:43
Methods to Enable Spatial Transcriptomics of Bone Tissues
Published on: May 3, 2024
Single-Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in
Hui Li1, Changjiang Sun2, Minjie Yang3
1Department of Endocrinology, Shaanxi Provincial People's Hospital, Xi'an City, Shaanxi Province, China.
International Journal of Genomics
|July 19, 2026
Summary
This study reveals the cellular complexity of osteosarcoma using single-cell RNA sequencing, identifying key genes like POSTN that may drive tumor progression and offer new therapeutic targets for this bone cancer.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Osteosarcoma is a prevalent pediatric bone cancer with poor prognosis for metastatic disease.
- Understanding the tumor microenvironment's cellular complexity is crucial for targeted therapies.
Purpose of the Study:
- To perform single-cell RNA sequencing on osteosarcoma to identify cellular heterogeneity.
- To discover novel candidate genes and pathways involved in osteosarcoma progression.
Main Methods:
- Single-cell RNA sequencing and bioinformatic analysis (Seurat, PCA, UMAP, Louvain clustering).
- Differential gene expression analysis and functional enrichment (Gene Ontology, KEGG pathways).
- Validation of candidate genes (F11, ACRP2, LEPR, POSTN) using qRT-PCR and ELISA.
Main Results:
- Seven distinct cell clusters were identified, including macrophages, osteoblasts, fibroblasts, proliferating cells, osteoclasts, monocytes, and T cells.
- Key pathways identified include PI3K-Akt signaling and extracellular matrix organization.
- POSTN, LEPR, and ACRP2 were significantly upregulated, while F11 was downregulated at both mRNA and protein levels.
Conclusions:
- Single-cell transcriptomics provides an atlas of osteosarcoma cellular heterogeneity.
- F11, ACRP2, LEPR, and POSTN are potential biomarkers for osteosarcoma.
- POSTN shows significant upregulation and may play a role in matrix remodeling, warranting further investigation as a therapeutic target.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...